VANI - Vivani Medical Inc.

VANI - Vivani Medical Inc.

https://www.vivani.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit

Zacks Commentary • 3 months, 1 week ago • score: 0.30

VANI is set to spin off Cortigent, aiming to sharpen its focus on drug implants and unlock long-term value for both entities.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$1.80

52W Low

$0.91

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

3.24

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.93

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

15.57

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

49.04%

Institutions (25–75% balanced)

6.84%

Shares Outstanding

59,244,000

Float

30,972,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

130,000

EPS (TTM)

-0.45

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.78%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.0272

Previous

-0.0260

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025